Dora Trevino, APRN
Family · San Antonio, TXNPI 1215519731
Payments from drug & device makers
Across 167 payments — averaging $61.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$2K
- MML US, Inc.$2K
- Relievant Medsystems, Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$499
- Abbott$311
- plus $743 from 11 others
What the payments were for
- Travel & lodging$5,10350%
- Food & beverage$5,01949%
- Education$1832%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 53 | $3,840 |
| Boston Scientific | 16 | $2,066 |
| MML US, Inc. | 14 | $1,746 |
| Relievant Medsystems, Inc. | 8 | $1,099 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 36 | $499 |
| Abbott | 7 | $311 |
| Globus Medical | 4 | $123 |
| AbbVie | 6 | $110 |
| SPR Therapeutics, Inc | 3 | $93 |
| Novo Nordisk | 4 | $81 |
| Astellas Pharma US Inc | 1 | $75 |
| Collegium Pharmaceutical, Inc. | 4 | $71 |
| Lilly USA, LLC | 4 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Amgen | 2 | $32 |
| Valinor Pharma, LLC | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,924
- ReActiv8$1,408
- VANTA ADAPTIVESTIM$1,172
- SYNCHROMEDII$1,081
- SPECTRA WAVEWRITER$960
- WaveWriter Alpha Prime 16$736
- INTELLIS ADAPTIVESTIM$280
- Superion Indirect Decompression System$108
How this compares
$10,304 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 86 | $11,518 |
| Gabapentin | 400 | $6,321 |
| Buprenorphine | 12 | $4,043 |
| Celecoxib | 151 | $3,654 |
| Baclofen | 199 | $3,021 |
| Tizanidine Hcl | 222 | $3,009 |
| Duloxetine Hcl | 132 | $2,315 |
| Lubiprostone | 16 | $2,106 |
| Diclofenac Sodium | 53 | $2,063 |
| Amitriptyline Hcl | 199 | $1,961 |
| Pregabalin | 79 | $1,814 |
| Cyclobenzaprine Hcl | 101 | $1,470 |
| Methocarbamol | 65 | $908 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 38 | $866 |
| Tramadol Hcl ErTramadol Hcl | 14 | $801 |
Paid to pharmacies, not to this prescriber.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.